S Malik1, F R Balkwill. Show Affiliations » 1. Imperial Cancer Research Fund Laboratories, London.
Abstract
Entities: Disease
Mesh: See more » HumansNeoplasms/drug therapyRecombinant Proteins/therapeutic useTumor Necrosis Factor-alpha/physiologyTumor Necrosis Factor-alpha/therapeutic use
Substances: See more » Recombinant ProteinsTumor Necrosis Factor-alpha
Year: 1988 PMID: 3133019 PMCID: PMC2545699 DOI: 10.1136/bmj.296.6631.1214
Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN: 0267-0623